Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients

J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1407-9. doi: 10.1136/jnnp-2012-303664. Epub 2013 Jun 12.
No abstract available

Keywords: Myasthenia; Neuroimmunology; Neuromuscular.

Publication types

  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Murine-Derived / adverse effects
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Autoantibodies / immunology*
  • Drug Resistance / drug effects
  • Female
  • Humans
  • Male
  • Myasthenia Gravis / drug therapy*
  • Myasthenia Gravis / immunology*
  • Receptor Protein-Tyrosine Kinases / antagonists & inhibitors
  • Receptor Protein-Tyrosine Kinases / immunology*
  • Receptors, Cholinergic / immunology*
  • Retrospective Studies
  • Rituximab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Autoantibodies
  • Receptors, Cholinergic
  • Rituximab
  • MUSK protein, human
  • Receptor Protein-Tyrosine Kinases